Skip to main content
. 2020 Jun 15;47(13):3058–3065. doi: 10.1007/s00259-020-04913-9

Table 3.

Summary of adverse events

Pain, N

  Requiring interruption of the procedure

  Resolving upon interruption of the procedure

  Requiring any drug intervention

4

3

4

0

Hematoma within the biopsy site, N 3
Contrast medium extravasation, N 1

Contrast medium-associated cutaneous rash, N

  Requiring interruption of the procedure

  Resolving upon interruption of the procedure

  Requiring any drug intervention

1

0

0

0